Electroconvulsive therapy (ECT) in Parkinson's disease: ECS and dopamine enhancement

Journal of ECT

Volumn 30, Issue 2, 2014, Pages 122-124

  Cumper, Samantha K ^a   Ahle, Gabriella M ^a   Liebman, Lauren S ^a   Kellner, Charles H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; ECS; ECT; Electroconvulsive; Electroconvulsive shock; Parkinson disease; Striatum

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR;

CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; ELECTROCONVULSIVE THERAPY; HUMAN; PARKINSON DISEASE; REVIEW; ANIMAL; ELECTRIC SHOCK; METABOLISM; PROCEDURES;

ANIMALS; DOPAMINE; ELECTROCONVULSIVE THERAPY; ELECTROSHOCK; PARKINSON DISEASE;

EID: 84901637045     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0000000000000142     Document Type: Review

References (28)

1. Popeo D, Kellner CH. ECT for Parkinson's disease. Med Hypotheses. 2009;73:468-469, doi:10.1016/j.mehy.2009.06.053 S0306-9877(09) 00485-X [pii].
2. Worth PF. When the going gets tough: how to select patients with Parkinson's disease for advanced therapies. Pract Neurol. 2013;13: 140-152, doi:10.1136/practneurol-2012-000463 practneurol-2012-000463 [pii].
3. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006;355: 896-908, doi:355/9/896 [pii] 10.1056/NEJMoa060281. (Pubitemid 44315982)
4. Fromm. Observations on the effect of electroshock treatment on patients with parkinsonism. Bull Tulane Univ Med Fac. 1959;18:71-73.
5. Kennedy R,Mittal D, O'Jile J. Electroconvulsive therapy in movement disorders: An update. J Neuropsychiatry Clin Neurosci. 2003;15:407-421. (Pubitemid 37444583)
6. Andersen K, Balldin J, Gottfries CG, et al. A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with "on-off " phenomena. Acta Neurol Scand. 1987;76:191-199. (Pubitemid 17144130)
7. Fochtmann L. A Mechanism for the Efficacy of ECT in Parkinson's Disease. Convuls Ther. 1988;4:321-327. (Pubitemid 19010803)
8. Fochtmann LJ. Animal studies of electroconvulsive therapy: foundations for future research. Psychopharmacol Bull. 1994;30:321-444.
9. Glue P, Costello MJ, Pert A, et al. Regional neurotransmitter responses after acute and chronic electroconvulsive shock. Psychopharmacology (Berl). 1990;100:60-65. (Pubitemid 20015672)
10. Nomikos GG, Zis AP, Damsma G, et al. Electroconvulsive shock produces large increases in interstitial concentrations of dopamine in the rat striatum: An in vivo microdialysis study. Neuropsychopharmacology. 1991;4:65-69.
11. Zis AP, Nomikos GG, Damsma G, et al. In vivo neurochemical effects of electroconvulsive shock studied by microdialysis in the rat striatum. Psychopharmacology (Berl). 1991;103:343-350.
12. Yoshida K, Higuchi H, Kamata M, et al. Dopamine releasing response in rat striatum to single and repeated electroconvulsive shock treatment. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21:707-715, doi:S0278584697000432 [pii]. (Pubitemid 27244180)
13. Rosa DV, Souza RP, Souza BR, et al. DARPP-32 expression in rat brain after electroconvulsive stimulation. Brain Res. 2007;1179:35-41, doi:S0006-8993(07)01945-2 [pii] 10.1016/j.brainres.2007.08.043. (Pubitemid 350001354)
14. Park HJ, Cui FJ, Roh JW, et al. Effects of electroconvulsive shock on the phosphorylation of DARPP-32 in rat striatum. Psychiatry Res. 2009;170:91-95, doi:10.1016/j.psychres.2008.07.002 S0165-1781(08) 00222-9 [pii].
15. Sershen H, et al. The effects of electroconvulsive shock on dopamine-1 and dopamine-2 receptor ligand binding activity in MPTP-treated mice. J Neuropsychiatry Clin Neurosci. 1991;3:58-63.
16. Brannan T, Martinez-Tica J, Yahr MD. Effect of repeated electroconvulsive shock on striatal L-dopa and dopamine metabolism: An in vivo study. J Neural Transm Park Dis Dement Sect. 1993;6:35-44. (Pubitemid 23284438)
17. Strome EM, Zis AP, Doudet DJ. Electroconvulsive shock enhances striatal dopamine D1 and D3 receptor binding and improvesmotor performance in 6-OHDA-lesioned rats. J Psychiatry Neurosci. 2007;32:193-202. (Pubitemid 46903860)
18. Anastasia A, de Erausquin GA, Wojnacki J, Masco DH. Protection of dopaminergic neurons by electroconvulsive shock in an animal model of Parkinson's disease. J Neurochem. 2007;103;1542-1552, doi:JNC4856 [pii] 10.1111/j.1471-4159.2007.04856.x. (Pubitemid 47631811)
19. Landau AM, Chakravarty MM, Clark CM, et al. Electroconvulsive therapy alters dopamine signaling in the striatum of non-human primates. Neuropsychopharmacology. 2011;36:511-518, doi:10.1038/npp.2010.182. npp2010182 [pii].
20. Landau AM, Clark C, Jivan S, et al. Antiparkinsonian mechanism of electroconvulsive therapy in MPTP-lesioned non-human primates. Neurodegener Dis. 2012;9:128-138, doi:10.1159/000334497 000334497 [pii].
21. Andrade C, et al. High but not low ECS stimulus intensity augments apomorphine-stimulated dopamine postsynaptic receptor functioning in rats. J ECT. 2002;18:80-83. (Pubitemid 35006024)
22. Tsen P, El Mansari M, Blier P. Effects of repeated electroconvulsive shocks on catecholamine systems: electrophysiological studies in the rat brain. Synapse. 2013;67:716-727, doi:10.1002/syn.21685.
23. Greenamyre JT, O'Brien CF. N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease. Arch Neurol. 1991;48:977-981.
24. Passarelli F, Carmenini E, Calo L, et al. E. Electroconvulsive shock blocks the opioid-mediated inhibition of dopamine release in rat striatal slices. J Neural Transm. 1997;104:805-810. (Pubitemid 27507328)
25. Altar CA, Whitehead RE, Chen R, et al. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry. 2003;54:703-709, doi: S0006322303000738 [pii]. (Pubitemid 37281386)
26. Bolwig TG. Blood-brain barrier studies with special reference to epileptic seizures. Acta Psychiatr Scand Suppl. 1988;345:15-20.
27. Costain DW, Cowen PJ, Gelder MG, et al. Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responses. Lancet. 1982;2:400-404, doi:S0140-6736(82)90438-X [pii]. (Pubitemid 12039834)
28. Wilkinson D, Daoud J. The stigma and the enigma of ECT. Int J Geriatr Psychiatry. 1998;13:833-835, doi:10.1002/(SICI)1099-1166(1998120) 13:12<833::AID-GPS884>3.0.CO;2-R [pii]. (Pubitemid 28564480)